Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Regulatory News:
Cellectis (Paris:ALCLS) (Alternext: ALCLS), the global genome engineering specialist, presented its consolidated financial statements for the 2012 fiscal year, approved for publication by the Board of Directors at their meeting today.
Help employers find you! Check out all the jobs and post your resume.
